|
JP2001509167A
(ja)
*
|
1997-01-24 |
2001-07-10 |
エイブイアイ バイオファーマ，インコーポレイテッド |
Ｈ．ｐｙｌｏｒｉ感染を処置するための方法および結合体
|
|
CA2280957A1
(en)
*
|
1997-02-14 |
1998-08-20 |
Leslie Orgel |
Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
|
|
ES2210761T3
(es)
|
1997-05-21 |
2004-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Composicion y procedimiento para mejorar el transporte a traves de las membranas biologicas.
|
|
US20020064520A1
(en)
*
|
1999-08-19 |
2002-05-30 |
Yanina Rozenberg |
Targeted artificial gene delivery
|
|
CA2381425A1
(en)
*
|
1999-08-24 |
2001-03-01 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
|
US7229961B2
(en)
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
EP3020804A1
(en)
|
2000-07-06 |
2016-05-18 |
Sarepta Therapeutics, Inc. |
Transforming growth factor beta (tgf- ) blocking agent-treated stem cell composition and method
|
|
AU2001284665B2
(en)
|
2000-07-21 |
2006-06-08 |
Revance Therapeutics, Inc. |
Multi-component Biological Transport Systems
|
|
JP2004523480A
(ja)
*
|
2000-08-22 |
2004-08-05 |
ニュー リバー ファーマシューティカルズ， インコーポレイテッド |
活性作用物質送達系ならびに活性作用物質の保護および投与方法
|
|
CA2428971A1
(en)
*
|
2000-11-14 |
2003-05-01 |
New River Pharmaceuticals Inc. |
Conjugates of a therapeutic agent and a peptide carrier
|
|
KR20040088519A
(ko)
*
|
2002-02-22 |
2004-10-16 |
뉴 리버 파마슈티칼스, 인크. |
활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
|
|
WO2004060403A2
(en)
|
2003-01-06 |
2004-07-22 |
Angiochem Inc. |
Aprotinin and anglos as carriers across the blood-brain barrier
|
|
US20050234002A1
(en)
|
2004-01-23 |
2005-10-20 |
Mourich Dan V |
Antisense oligomers and methods for inducing immune tolerance and immunosuppression
|
|
US8092788B2
(en)
|
2004-03-03 |
2012-01-10 |
Revance Therapeutics, Inc. |
Compositions and methods for topical diagnostic and therapeutic transport
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
PL1766012T3
(pl)
|
2004-07-02 |
2011-11-30 |
Avi Biopharma Inc |
Antysensowne, przeciwbakteryjne związki i sposoby
|
|
ES2852549T3
(es)
|
2005-02-09 |
2021-09-13 |
Sarepta Therapeutics Inc |
Composición antisentido para tratamiento de la atrofia muscular
|
|
PT1859041E
(pt)
|
2005-02-18 |
2012-06-19 |
Angiochem Inc |
Moléculas para transportar um composto através da barreira hematoencefálica
|
|
MX2007010673A
(es)
|
2005-03-03 |
2008-04-07 |
Revance Therapeutics Inc |
Composiciones y metodos para la aplicacion topica y el suministro transdermico de toxinas botulinicas.
|
|
KR20080016992A
(ko)
|
2005-03-03 |
2008-02-25 |
레반스 테라퓨틱스, 아이엔씨. |
올리고펩티드의 국소 적용 및 경피 전달을 위한 조성물 및방법
|
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
|
AU2006267051B2
(en)
|
2005-07-13 |
2013-03-07 |
Sarepta Therapeutics, Inc. |
Antisense antibacterial method and compound
|
|
EP1907009A4
(en)
|
2005-07-15 |
2009-09-02 |
Angiochem Inc |
USE OF APROTININ POLYPEPTIDES AS CARRIER IN PHARMACEUTICAL CONJUGATES
|
|
US8501704B2
(en)
|
2005-11-08 |
2013-08-06 |
Sarepta Therapeutics, Inc. |
Immunosuppression compound and treatment method
|
|
EP1935434A1
(en)
*
|
2006-12-19 |
2008-06-25 |
Novosom AG |
Construction and use of transfection enhancer elements
|
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
|
CA2718961C
(en)
|
2008-03-20 |
2014-12-16 |
University Of Florida Research Foundation, Inc. |
Enhancing vessel lesion homing and repair potential of stem cells
|
|
EP2143726A1
(en)
*
|
2008-07-11 |
2010-01-13 |
Novosom AG |
Nucleic acid comprising zwitterionic nucleotides
|
|
WO2010043047A1
(en)
|
2008-10-15 |
2010-04-22 |
Angiochem Inc. |
Conjugates of glp-1 agonists and uses thereof
|
|
EP2370471B1
(en)
|
2008-12-05 |
2017-02-22 |
Angiochem Inc. |
Neurotensin conjugate and uses thereof
|
|
WO2010080554A1
(en)
*
|
2008-12-17 |
2010-07-15 |
Avi Biopharma, Inc. |
Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
|
|
CA2759129C
(en)
|
2009-04-20 |
2018-12-11 |
Angiochem Inc. |
Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
|
|
US8450285B2
(en)
|
2009-06-05 |
2013-05-28 |
13Therapeutics, Inc. |
Immunoregulatory peptides and methods of use
|
|
CN102596993A
(zh)
|
2009-07-02 |
2012-07-18 |
安吉奥开米公司 |
多聚体肽结合物以及其应用
|
|
KR102182663B1
(ko)
|
2010-05-28 |
2020-11-25 |
사렙타 쎄러퓨틱스, 인코퍼레이티드 |
변형된 서브유니트간 결합 및/또는 말단 그룹을 갖는 올리고뉴클레오타이드 유사체
|
|
WO2012031243A2
(en)
|
2010-09-03 |
2012-03-08 |
Avi Biopharma, Inc. |
dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
|
|
US8580748B2
(en)
|
2011-04-06 |
2013-11-12 |
13Therapeutics, Inc. |
Peptides for the treatment of hearing
|
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
|
CN111808135A
(zh)
|
2011-11-18 |
2020-10-23 |
萨勒普塔医疗公司 |
功能改性的寡核苷酸及其亚单元
|
|
CN104411831B
(zh)
|
2012-03-20 |
2020-08-11 |
萨勒普塔医疗公司 |
寡核苷酸类似物的硼酸缀合物
|
|
GB201210358D0
(en)
*
|
2012-06-12 |
2012-07-25 |
Polytherics Ltd |
Complexes
|
|
JP2015526434A
(ja)
|
2012-08-14 |
2015-09-10 |
アンジオケム インコーポレーテッド |
ペプチド−デンドリマーコンジュゲート及びその使用
|
|
MA41795A
(fr)
|
2015-03-18 |
2018-01-23 |
Sarepta Therapeutics Inc |
Exclusion d'un exon induite par des composés antisens dans la myostatine
|
|
EP3302489A4
(en)
|
2015-06-04 |
2019-02-06 |
Sarepta Therapeutics, Inc. |
METHOD AND COMPOUNDS FOR THE TREATMENT OF DISEASES AND SUFFERING IN CONNECTION WITH LYMPHOCYTES
|
|
JP6823055B2
(ja)
|
2015-06-15 |
2021-01-27 |
アンジオケム インコーポレーテッド |
軟髄膜癌腫症の治療方法
|
|
JP6863973B2
(ja)
*
|
2015-10-07 |
2021-04-21 |
コーメディクス・インコーポレーテッド |
タウロリジンの皮膚浸透製剤
|
